Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.

Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ.

Cell. 2009 Dec 24;139(7):1243-54. doi: 10.1016/j.cell.2009.12.017.

2.

IFITM proteins restrict antibody-dependent enhancement of dengue virus infection.

Chan YK, Huang IC, Farzan M.

PLoS One. 2012;7(3):e34508. doi: 10.1371/journal.pone.0034508. Epub 2012 Mar 30.

3.

Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections.

Jiang D, Weidner JM, Qing M, Pan XB, Guo H, Xu C, Zhang X, Birk A, Chang J, Shi PY, Block TM, Guo JT.

J Virol. 2010 Aug;84(16):8332-41. doi: 10.1128/JVI.02199-09. Epub 2010 Jun 9.

4.

Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro.

Smith SE, Gibson MS, Wash RS, Ferrara F, Wright E, Temperton N, Kellam P, Fife M.

J Virol. 2013 Dec;87(23):12957-66. doi: 10.1128/JVI.01443-13. Epub 2013 Sep 25.

5.

Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.

Blyth GA, Chan WF, Webster RG, Magor KE.

J Virol. 2015 Oct 14;90(1):103-16. doi: 10.1128/JVI.01593-15.

6.

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.

Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, Gaiha GD, Ryan BJ, Donis RO, Elledge SJ, Brass AL.

PLoS Pathog. 2011 Oct;7(10):e1002337. doi: 10.1371/journal.ppat.1002337. Epub 2011 Oct 27.

7.

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.

Bailey CC, Zhong G, Huang IC, Farzan M.

Annu Rev Virol. 2014 Nov 1;1:261-283.

8.

Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.

Lin TY, Chin CR, Everitt AR, Clare S, Perreira JM, Savidis G, Aker AM, John SP, Sarlah D, Carreira EM, Elledge SJ, Kellam P, Brass AL.

Cell Rep. 2013 Nov 27;5(4):895-908. doi: 10.1016/j.celrep.2013.10.033. Epub 2013 Nov 21.

9.

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.

Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, Brass AL, Ahmed AA, Chi X, Dong L, Longobardi LE, Boltz D, Kuhn JH, Elledge SJ, Bavari S, Denison MR, Choe H, Farzan M.

PLoS Pathog. 2011 Jan 6;7(1):e1001258. doi: 10.1371/journal.ppat.1001258.

10.

The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus.

Warren CJ, Griffin LM, Little AS, Huang IC, Farzan M, Pyeon D.

PLoS One. 2014 May 14;9(5):e96579. doi: 10.1371/journal.pone.0096579. eCollection 2014.

11.

Host factors involved in West Nile virus replication.

Brinton MA.

Ann N Y Acad Sci. 2001 Dec;951:207-19. Review.

PMID:
11797778
12.

IFITMs restrict the replication of multiple pathogenic viruses.

Perreira JM, Chin CR, Feeley EM, Brass AL.

J Mol Biol. 2013 Dec 13;425(24):4937-55. doi: 10.1016/j.jmb.2013.09.024. Epub 2013 Sep 25. Review.

13.

IFITM3 restricts the morbidity and mortality associated with influenza.

Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB; GenISIS Investigators; MOSAIC Investigators, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam P.

Nature. 2012 Mar 25;484(7395):519-23. doi: 10.1038/nature10921.

14.

IFITM proteins restrict viral membrane hemifusion.

Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M, Ding S, He Y, Liang C, Lee JC, Gratton E, Cohen FS, Liu SL.

PLoS Pathog. 2013 Jan;9(1):e1003124. doi: 10.1371/journal.ppat.1003124. Epub 2013 Jan 24.

15.

Fatal persistence of West Nile virus subtype Kunjin in the brains of flavivirus resistant mice.

Shueb RH, Papadimitriou J, Urosevic N.

Virus Res. 2011 Feb;155(2):455-61. doi: 10.1016/j.virusres.2010.12.001. Epub 2010 Dec 15.

PMID:
21167228
16.

Swine interferon-inducible transmembrane proteins potently inhibit influenza A virus replication.

Lanz C, Yángüez E, Andenmatten D, Stertz S.

J Virol. 2015 Jan;89(1):863-9. doi: 10.1128/JVI.02516-14. Epub 2014 Oct 15. Erratum in: J Virol. 2015 Mar;89(5):2988.

17.

Genome-wide RNAi screen identifies broadly-acting host factors that inhibit arbovirus infection.

Yasunaga A, Hanna SL, Li J, Cho H, Rose PP, Spiridigliozzi A, Gold B, Diamond MS, Cherry S.

PLoS Pathog. 2014 Feb 13;10(2):e1003914. doi: 10.1371/journal.ppat.1003914. eCollection 2014 Feb.

18.

IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.

Mudhasani R, Tran JP, Retterer C, Radoshitzky SR, Kota KP, Altamura LA, Smith JM, Packard BZ, Kuhn JH, Costantino J, Garrison AR, Schmaljohn CS, Huang IC, Farzan M, Bavari S.

J Virol. 2013 Aug;87(15):8451-64. doi: 10.1128/JVI.03382-12. Epub 2013 May 29.

19.

Antiviral macrophage responses in flavivirus encephalitis.

Ashhurst TM, Vreden Cv, Munoz-Erazo L, Niewold P, Watabe K, Terry RL, Deffrasnes C, Getts DR, Cole King NJ.

Indian J Med Res. 2013 Nov;138(5):632-47. Review.

20.

A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.

Martina BE, van den Doel P, Koraka P, van Amerongen G, Spohn G, Haagmans BL, Provacia LB, Osterhaus AD, Rimmelzwaan GF.

PLoS One. 2011 Apr 26;6(4):e18995. doi: 10.1371/journal.pone.0018995.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk